Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis
Open Access
- 1 November 2009
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 50 (11) , 2299-2305
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Oxidative stress and its association with coronary artery disease and different atherogenic risk factorsJournal of Internal Medicine, 2004
- Phosphorylation and Stabilization of ATP Binding Cassette Transporter A1 by Synthetic Amphiphilic Helical PeptidesJournal of Biological Chemistry, 2004
- Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density LipoproteinJournal of Biological Chemistry, 2004
- ABCA1-mediated Cholesterol Efflux Is Defective in Free Cholesterol-loaded MacrophagesJournal of Biological Chemistry, 2002
- Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated DegradationJournal of Biological Chemistry, 2002
- Effect of Probucol in Lecithin-Cholesterol Acyltransferase–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Selective Inhibition of Free Apolipoprotein-Mediated Cellular Lipid Efflux by ProbucolBiochemistry, 1996
- Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- A little more information about aggravation of probucol-induced HDL-reduction by clofibrateAtherosclerosis, 1988
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986